Authors


Rohan C. Parikh, MS

Latest:

Cost-Utility Analysis of Treatments for Advanced Non-Small Cell Lung Cancer

A national community-level study of Medicare patients with advanced non-small cell lung cancer found that adding targeted therapy to chemotherapy regimens was not cost-effective.


Nathan Spann, PharmD

Latest:

Patient Engagement Strategies for Immunization in a Community Pharmacy Setting

Prior to vaccines, immunity to a disease was acquired solely through contracting the illness.



Brittany Hoffman-Eubanks

Latest:

The Role of Pharmacy Benefit Mangers in American Health Care: Pharmacy Concerns and Perspectives: Part 3

There have been multiple concerns levied about PBM tactics that have led plan sponsors and pharmacy stakeholders to push back.


Kristie L. Kahl

Latest:

Oxybutynin May Provide Hot Flash Treatment Option in Breast Cancer Survivors

Hot flashes are a huge problem across the general population, but even more so in breast cancer survivors.


Linda L. Schock

Latest:

The Challenges and Rewards of Launching an Orphan Drug

With orphan drugs under the microscope, it's important to review the special circumstances and challenges of this group.


Geoffrey Brown, PharmD Candidate

Latest:

Pharmacologic Treatment Challenges for IBD

Irritable bowel disease, which is defined as chronic idiopathic inflammation of the digestive tract, affects 3.1 million adults in the United States.


R. Houston Thompson, MD

Latest:

Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell Carcinoma

Study investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.



Joshua Blackwell, PharmD, MS

Latest:

Fostering Rapid Innovation During a Time of Crisis

Promoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.


Amy Jacob

Latest:

New Treatment for Progressive Multiple Sclerosis on the Horizon

Relationship between MS and common herpes virus Epstein-Barr virus offer new treatment target.


Kate H. Gamble

Latest:

Presidential Candidate's Disclosure of Migraine Helps Increase Awareness

Discussion around Michele Bachmann's condition has brought migraine management to the forefront.


Jennifer Nessel, Assistant Editor

Latest:

Drug Combination Leads to Progression-Free Survival in Patients With Cancer

A randomized clinical trial offers strong evidence that a combination of 2 targeted melanoma drugs when given continuously keeps cancer from growing or spreading longer compared with intermittent treatment.


Sarah Peters

Latest:

Ado-trastuzumab Emtansine (Kadcyla)

This human epidermal growth factor receptor 2 (HER2)-targeted antibody-drug conjugate is approved for the treatment of patients with HER2-positive, metastatic breast cancer.


Sarah K. Milam, PharmD

Latest:

Anticoagulation Monitoring: The Next Community Pharmacy Value Proposition

An independent pharmacy in Virginia provides patient care services through an anticoagulation clinic.


Alexandra M. Williams, 340B ACE, And Halena Leah Marcelin, PharmD, MS, BCPS

Latest:

Documenting 340B Value Is Key to Success

This helps ensure that participation increases access to and care of patients of the covered entity.


Karen E. Van Nuys, PhD

Latest:

Practice Economics and the Decision to Prescribe Oral Oncolytics

This paper explores the economic incentives that oncologists face when deciding between oral and intravenous oncolytics and their impact on prescribing behavior.



Pamela Wolfe, MS

Latest:

Impact of Medicare Part D on Utilization and Expenditures

Examination of pharmacy behaviors before and after implementation indicated that restrictions in pharmacy benefits may not deter utilization for Part D.


Stephanie Whalen, PharmD

Latest:

THE PHARMACEUTICAL INDUSTRY: CONTRIBUTING TO BETTER MEDICINES

Drs. Patel, Singh, and Whalen are postdoctoral fellows in the Rutgers Pharmaceutical Industry Fellowship Program. Dr. Alexander is director of the Institute for Pharmaceutical Industry Fellowships, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey. Dr. Barone is professor and chair of the Department of Pharmacy Practice and Administration, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey.



Michelle N. Smith, PharmD

Latest:

Kicking the Habit With Combination Therapy: Updates in Tobacco Cessation Treatment

As one of the most visible members of the health care team, pharmacists are uniquely positioned to assist and support patients in tobacco cessation.


Shane Desselle, RPh, PhD, FAPhA

Latest:

Tip of the Week: Learn Business Skills for the New Pharmacist

In querying pharmacists about what is required to be successful, many so-called “soft skills” in the social and administrative sciences rise to the top, but more evidence is needed.


Marc Stranz, PharmD

Latest:

Opportunities and Trends in Digital Health

The past decade has seen a rapid expansion in technology adoption.


Christine G. Kohn, PharmD

Latest:

Case Studies (March 2018)

What should these pharmacists do?


Ana M. Palacio, MD, MPH

Latest:

Healthcare Utilization and Costs for Insured Patients With Fibromyalgia

Fibromyalgia was related to a pattern of initial increase in utilization and costs, followed by a decrease 7 to 12 months after diagnosis.


Robert J. Irene, RPh, BSPharm, President, Armada Health Care, PBMI 2012 Specialty Drug Benefit Report

Latest:

The Remaking of Specialty Pharmacy

Pharmacies with a vision of the future can participate in this thriving market. Small chains and even retailers are establishing a foothold in specialty pharmacy, and they are thriving, while traditional retailers are finding ways to participate actively.



Adriana Matos, PharmD, BCGP

Latest:

Consider Impact of Certain Medications on Brain Function

Pharmacists can identify drugs that cause problems, guide selection, and recommend treatment strategies.